| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| EBITDA | −179 | 391 | — |
| Profit before tax | −179 | 391 | — |
| Net profit | −244 | 392 | — |
| EPS | −₹1.47 | ₹2.43 | — |
| Tap a line for its trend | Q1 FY27Jun 2026 | Q4 FY26Mar 2026 | Q3 FY26Dec 2025 | Q2 FY26Sep 2025 | Q1 FY26Jun 2025 | Q4 FY25Mar 2025 |
|---|
Expenses | ||||||
|---|---|---|---|---|---|---|
| −179 | 446 | 372 | 23.4 | 391 | 502 | |
| −179 | 446 | 372 | 23.4 | 391 | 502 | |
Profit | ||||||
| −179 | 446 | 372 | 23.4 | 391 | 502 | |
| −244 | 564 | 377 | 20.1 | 392 | 322 | |
Per share | ||||||
| −₹1.47 | ₹3.51 | ₹2.31 | ₹0.33 | ₹2.43 | ₹2.18 | |
Revenue detail — as filed | ||||||
| 11,300 | 11,840 | 11,429 | 12,340 | 11,081 | 11,009 | |
| 1,553 | 1,818 | 1,658 | 2,884 | 1,657 | 1,656 | |
Expense detail — as filed | ||||||
| 796 | 998 | 1,309 | 1,515 | 666 | 264 | |
| 954 | 962 | 1,048 | 922 | 934 | 1,094 | |
| 954 | 962 | 1,048 | 922 | 934 | 1,094 | |
| 17.1 | 18.5 | 16.6 | 16.6 | 11.2 | 34.8 | |
| −0.4 | 2.4 | 0.3 | 0.4 | 1.0 | −92.0 | |
| 15.1 | 672 | 351 | 307 | 351 | 725 | |
| 6.5 | 7.0 | 6.4 | 6.4 | 4.4 | 14.3 | |
| −0.2 | 0.9 | 0.1 | 0.2 | 186 | 713 | |
Profit build-up — alternate / pre-Ind-AS tags | ||||||
| −179 | 446 | 372 | 23.4 | 391 | 502 | |
| −179 | 446 | 372 | 23.4 | 391 | 502 | |
| 65.3 | −118 | −4.7 | 3.3 | −1.3 | 181 | |
| −244 | 564 | 377 | 20.1 | 392 | 322 | |
| −243 | 578 | 380 | 54.1 | 400 | 359 | |
Per share — as-filed variants | ||||||
| −₹1.47 | ₹3.51 | ₹2.31 | ₹0.33 | ₹2.43 | ₹2.18 | |
| −₹1.47 | ₹3.51 | ₹2.31 | ₹0.33 | ₹2.43 | ₹2.18 | |
Appropriations & transfers | ||||||
| −790 | −12.5 | −82.9 | −672 | −97.8 | 495 | |
| 23,654 | 23,802 | 22,699 | 22,232 | 22,373 | 21,932 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Insurance — revenue account (Policyholders') | ||||||
| 9,747 | 10,022 | 9,771 | 9,455 | 9,424 | 9,352 | |
| 13,835 | 11,727 | 11,763 | 10,645 | 13,446 | 11,528 | |
| 11,298 | 10,063 | 9,717 | 8,869 | 10,902 | 9,800 | |
| 1,100 | 1,317 | 1,605 | 1,843 | 864 | 588 | |
| 8.8 | 664 | 345 | 300 | 161 | −1.8 | |
| 9,370 | 8,818 | 8,770 | 8,772 | 8,286 | 8,638 | |
| 10,036 | 9,574 | 8,858 | 10,247 | 9,381 | 8,831 | |
| 666 | 757 | 87.8 | 1,475 | 1,095 | 193 | |
Insurance — Shareholders' account | ||||||
| −164 | 1,118 | 723 | 330 | 743 | 1,228 | |
| 600 | 704 | 641 | 1,110 | 638 | 655 | |
| −790 | −12.5 | −82.9 | −672 | −97.8 | 495 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | |
Insurance — result & transfers | ||||||
| −2,343 | −1,831 | −1,741 | −3,556 | −1,754 | −1,161 | |
| −790 | −12.5 | −82.9 | −672 | −97.8 | 495 | |
| 26.5 | 427 | 166 | −108 | 202 | 76.8 | |
Insurance — fund NPAs | ||||||
| 146 | 150 | 151 | 151 | 151 | 151 | |
| ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | |
Insurance — IRDAI ratios (as filed, not percentages) | ||||||
| 1.80× | 1.84× | 1.81× | 1.79× | 1.87× | 1.91× | |
| ₹0.02 | ₹0.02 | ₹0.02 | ₹0.02 | ₹0.02 | ₹0.02 | |
| ₹1.21 | ₹1.18 | ₹1.18 | ₹1.40 | ₹1.16 | ₹1.12 | |
| ₹1.03 | ₹0.96 | ₹0.91 | ₹1.08 | ₹1.00 | ₹0.94 | |
| ₹0.82 | ₹0.86 | ₹0.83 | ₹0.83 | ₹0.81 | ₹0.85 | |
| ₹0.17 | ₹0.21 | ₹0.17 | ₹0.28 | ₹0.15 | ₹0.15 | |
Regulatory disclosures — filed alongside, not part of the P&L | ||||||
| ₹0.00 | ₹0.00 | ₹1.00 | ₹3.00 | ₹0.00 | ₹0.00 | |
| ₹0.00 | ₹0.00 | ₹1.00 | ₹3.00 | ₹0.00 | ₹0.00 | |
| 0.9% | 0.9% | 0.9% | 0.9% | 0.9% | 0.9% | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 3 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|
| Expenses | |||||||
| EBITDA | 502.4 | 391.1 | 23.4 | 372.2 | 446.1 | -178.7 | |
| EBIT | 502.4 | 391.1 | 23.4 | 372.2 | 446.1 | -178.7 | |
| Profit | |||||||
| Pretax Income | 502.4 | 391.1 | 23.4 | 372.2 | 446.1 | -178.7 | |
| Net Income | 321.6 | 392.4 | 20.1 | 376.9 | 564.2 | -243.9 | |
| Per Share | |||||||
| Basic EPS | 2.18 | 2.43 | 0.33 | 2.31 | 3.51 | -1.47 | |
| Revenue Detail — as filed | |||||||
| + Operating Income | 11,008.7 | 11,080.5 | 12,339.7 | 11,428.6 | 11,840.1 | 11,300.1 | |
| + Income from Investments (net) | 1,656.3 | 1,656.5 | 2,884.3 | 1,657.7 | 1,818.3 | 1,552.8 | |
| Expense Detail — as filed | |||||||
| + Employee Remuneration & Welfare | 263.5 | 666.4 | 1,514.6 | 1,308.6 | 997.6 | 796.3 | |
| + Commission (net) | 1,094.5 | 933.5 | 922.0 | 1,048.2 | 961.7 | 954.0 | |
| + Commission & Brokerage (net) | 1,094.5 | 933.5 | 922.0 | 1,048.2 | 961.7 | 954.0 | |
| + Provision — Diminution in Investments | 34.8 | 11.2 | 16.6 | 16.6 | 18.5 | 17.1 | |
| + Provision — Doubtful Debts & Write-offs | -92.0 | 1.0 | 0.4 | 0.3 | 2.4 | -0.4 | |
| + Non-operating Expense | 725.4 | 351.4 | 307.0 | 351.2 | 672.2 | 15.1 | |
| + Non-operating Provision — Diminution in Investments | 14.3 | 4.4 | 6.4 | 6.4 | 7.0 | 6.5 | |
| + Non-operating Provision — Doubtful Debts | 712.9 | 186.3 | 0.2 | 0.1 | 0.9 | -0.2 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||||
| Profit before Extraordinary Items | 502.4 | 391.1 | 23.4 | 372.2 | 446.1 | -178.7 | |
| Profit / (Loss) before Tax — alt tag | 502.4 | 391.1 | 23.4 | 372.2 | 446.1 | -178.7 | |
| + Provision for Tax | 180.8 | -1.3 | 3.3 | -4.7 | -118.0 | 65.3 | |
| Profit / (Loss) after Tax | 321.6 | 392.4 | 20.1 | 376.9 | 564.2 | -243.9 | |
| Profit Carried to Balance Sheet | 358.6 | 400.3 | 54.1 | 380.0 | 577.9 | -242.7 | |
| Per Share — as-filed variants | |||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 2.18 | 2.43 | 0.33 | 2.31 | 3.51 | -1.47 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 2.18 | 2.43 | 0.33 | 2.31 | 3.51 | -1.47 | |
| Appropriations & Transfers | |||||||
| + Transfer to Profit & Loss Account | 495.5 | -97.8 | -671.9 | -82.9 | -12.5 | -789.7 | |
| Reserves & Surplus excl. Revaluation Reserve | 21,932.1 | 22,373.4 | 22,232.2 | 22,699.0 | 23,802.1 | 23,654.1 | |
| + Final Dividend | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — Revenue Account (Policyholders') | |||||||
| Premium Earned | 9,352.5 | 9,424.0 | 9,455.4 | 9,771.0 | 10,021.8 | 9,747.3 | |
| + Gross Premiums Written | 11,528.2 | 13,445.5 | 10,644.7 | 11,762.8 | 11,727.0 | 13,835.1 | |
| + Net Premium Written | 9,800.2 | 10,902.3 | 8,869.4 | 9,716.7 | 10,062.6 | 11,297.9 | |
| + Operating Expenses — Insurance Business | 587.6 | 863.8 | 1,842.7 | 1,605.5 | 1,316.6 | 1,099.9 | |
| + Non-operating Expenses — Non-insurance | -1.8 | 160.8 | 300.4 | 344.7 | 664.2 | 8.8 | |
| + Claims Paid | 8,637.9 | 8,286.1 | 8,772.1 | 8,770.2 | 8,817.6 | 9,369.7 | |
| + Incurred Claims | 8,831.2 | 9,381.0 | 10,246.9 | 8,858.0 | 9,574.2 | 10,035.9 | |
| + Change in Outstanding Claims | 193.3 | 1,094.9 | 1,474.8 | 87.8 | 756.6 | 666.2 | |
| Insurance — Shareholders' Account | |||||||
| + Income — Shareholders' Account | 1,227.8 | 742.5 | 330.3 | 723.4 | 1,118.3 | -163.6 | |
| + Shareholders' Investment Income | 655.5 | 638.5 | 1,110.0 | 640.6 | 703.8 | 599.6 | |
| + Transfer from Policyholders' Fund | 495.5 | -97.8 | -671.9 | -82.9 | -12.5 | -789.7 | |
| With Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Without Unrealised Gains | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Insurance — Result & Transfers | |||||||
| Underwriting Profit / (Loss) | -1,160.8 | -1,754.3 | -3,556.2 | -1,740.6 | -1,830.8 | -2,342.5 | |
| Operating Profit / (Loss) | 495.5 | -97.8 | -671.9 | -82.9 | -12.5 | -789.7 | |
| + Other Income — Shareholders' Account | 76.8 | 201.8 | -107.8 | 165.7 | 427.0 | 26.5 | |
| Insurance — Fund NPAs | |||||||
| + Gross NPAs — Policyholders' Fund | 150.6 | 150.6 | 150.6 | 150.6 | 150.3 | 146.3 | |
| + Gross NPA % — Policyholders' Fund | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||||
| Solvency Ratio (x, one scale) | 1.91 | 1.87 | 1.79 | 1.81 | 1.84 | 1.80 | |
| Solvency Ratio (as filed) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Combined Ratio | 1.12 | 1.16 | 1.40 | 1.18 | 1.18 | 1.21 | |
| Incurred Claim Ratio | 0.94 | 1.00 | 1.08 | 0.91 | 0.96 | 1.03 | |
| Net Retention Ratio | 0.85 | 0.81 | 0.83 | 0.83 | 0.86 | 0.82 | |
| Expenses of Management Ratio | 0.15 | 0.15 | 0.28 | 0.17 | 0.21 | 0.17 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||
| Investor Complaints — Received | 0.00 | 0.00 | 3.00 | 1.00 | 0.00 | 0.00 | |
| Investor Complaints — Disposed | 0.00 | 0.00 | 3.00 | 1.00 | 0.00 | 0.00 | |
| Government of India Shareholding % | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||
| Operating Expenses | 10,513.3 | 11,178.3 | 13,011.6 | 11,511.6 | 11,852.5 | 12,089.8 | |
| Other Operating Expenses | 324.0 | 197.4 | 328.1 | 296.9 | 319.0 | 303.6 | |
The New India Assurance (NSE: NIACL) will announce its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026, according to the board-meeting notice it filed on 23 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net loss was ₹244 crore, against a profit of ₹392 crore in Q1 FY26 and against a profit of ₹564 crore in Q4 FY26.
On 30 October 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 23 October 2026). Last year it reported Q2 FY26 on 13 November 2025.
With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹20.1 crore. The latest quarter, Q1 FY27, had a net loss of ₹244 crore.
Consolidated net loss was ₹244 crore, against a profit of ₹392 crore in Q1 FY26 and against a profit of ₹564 crore in Q4 FY26.
Net profit by quarter: a profit of ₹20.1 crore in Q2 FY26, a profit of ₹377 crore in Q3 FY26, a profit of ₹564 crore in Q4 FY26 and a loss of ₹244 crore in Q1 FY27. That is a combined profit of ₹717 crore over the four quarters.
Consolidated net profit was ₹1,354 crore in FY26 (April 2025–March 2026), up 39.2% from ₹972 crore in FY25.
From The New India Assurance's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.
Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.